Prosecution Insights
Last updated: November 04, 2026
Application No. 18/985,303

METHOD OF MAKING MEDICAL TUBE SECUREMENT DEVICE AND RELATED PRODUCTS

Non-Final OA §102§103
Filed
Dec 18, 2024
Priority
Jan 14, 2022 — provisional 63/299,713 +2 more
Examiner
ULSH, DUNG T
Art Unit
3783
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Kmd Surgical Solutions Inc.
OA Round
1 (Non-Final)
79%
Grant Probability
Favorable
1-2
OA Rounds
1y 1m
Est. Remaining
96%
With Interview

Examiner Intelligence

Grants 79% — above average
79%
Career Allowance Rate
307 granted / 390 resolved
+8.7% vs TC avg
Strong +17% interview lift
Without
With
+17.3%
Interview Lift
resolved cases with interview
Typical timeline
2y 11m
Avg Prosecution
26 currently pending
Career history
419
Total Applications
across all art units

Statute-Specific Performance

§101
1.0%
-39.0% vs TC avg
§103
39.3%
-0.7% vs TC avg
§102
30.4%
-9.6% vs TC avg
§112
23.4%
-16.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 390 resolved cases

Office Action

§102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Objections Claim(s) 46 is/are objected to because of the following informalities: Claim 46, no period at the end of the claim. Appropriate correction is required. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. Claim(s) 41-42 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Spinoza (US 2012/0022455). Regarding claim 41, Spinoza discloses A method of making a securement device or a product including a securement device (fig. 2a), wherein the securement device (fig. 2a) is configured to secure to a patient a medical tube when inserted into the patient (see fig. 2a and par. 0099), the method comprising: coupling a securement sleeve (210, fig. 2a) to a structural sheet (218/220) for an attachment pad (218/220); the securement sleeve (210) including a securement portion (210) through which the tube passage extends (Examiner notes: see fig. 6 for tube 612 extending through a securement sleeve), wherein a cross-sectional area of the tube passage in the securement portion transverse to a longitudinal path of the tube passage expands as the securement sleeve is shortened and contracts as the securement sleeve is lengthened (see pars. 0080-0081) and the length of the securement sleeve is adjustable to expand the cross-sectional area to receive a medical tube for translation through the tube passage in the securement portion and to contract the cross-sectional area to grip the medical tube in the tube passage by the securement portion to secure the medical tube to the securement device (see pars. 0080-0082); and the structural sheet (218/220) for the attachment pad (218/220) being configured with a proximal side to face a patient during use and a distal side to face away from a patient during use (see fig. 2a for proximal side and distal side of 218/220), the proximal side configured to be adhered with adhesive to skin of a patient (par. 0033); and wherein the coupling the securement sleeve (210) to the structural sheet (218/220) comprises: securing flared end material (216) of the securement sleeve (210), adjacent a proximal end (212) of the securement sleeve (210), between a first surface of a first securement member (surface of 220) and a second surface of a second securement member (surface of 218, see fig. 2a); and wherein the first securement member (220) is selected from the group consisting of the structural sheet with the first surface being on the distal side of the structural sheet and an intermediate member coupled, directly or indirectly, to the distal side of the structural sheet (see fig. 2a for 220 being the structural sheet with a surface being on the distal side of 218/220). Regarding claim 42, Spinoza discloses The method of claim 41, wherein the securing the flared end material (216) comprises sandwiching the flared end material (216) between and adhering the flared end material to both the first surface (surface of 220) to the second surface (surface of 218, see fig. 2a). Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 43-47 is/are rejected under 35 U.S.C. 103 as being unpatentable over Spinoza (US 2012/0022455) in view of Fangrow, JR (US 2007/0185454). Regarding claim 43, Spinoza discloses the method of claim 41, as set forth above, except for comprising; connecting a rotating member to a preliminary product form for the securement device, the preliminary product form including the structural sheet, wherein as connected to the preliminary product form the rotating member is rotatable relative to the structural sheet. However, Fangrow teaches a securement system comprising a rotating member (54) and the base member (60) wherein the rotating member is rotatable relative to the base member (pars. 0008, 0057, see figs. 5-6 and 10-14) and the structural sheet (50). It would have been obvious to one having ordinary skill in the art before the effective filling date of the claimed invention to modify Spinoza by adding a rotating member, as taught by Fangrow, for the purpose of further securing the securement sleeve in place. Regarding claim 44, see the rejection of claim 43. Regarding claim 45, Spinoza in view of Fangrow discloses the method of claim 44, Fangrow further teaches wherein the connecting the rotating member (54) to the preliminary product form (see figs. 10-14) comprises sliding the rotating member (54) over the securement sleeve (162) disposed through an aperture in the rotating member (see fig. 11) until the rotating member (54) engages a connection location on the preliminary product form (see fig. 11 and par. 0078). Regarding claim 46, Spinoza in view of Fangrow discloses the method of claim 44, Fangrow further teaches wherein: the connecting the rotating member (54) to the preliminary product form (see figs. 10-14) comprises engaging the rotating member (54) with exterior engagement features of an axle (62), and wherein as engaged with the axle the rotating member is rotatable about the axle (pars. 0008, 0057, and figs. 10-14). Regarding claim 47, Spinoza in view of Fangrow discloses the method of claim 43, Spinoza further discloses retaining a distal end portion of the securement sleeve (distal end portion of 210) in a distal collar assembly (214, fig. 2a and par. 0099). Claim(s) 48-50 is/are rejected under 35 U.S.C. 103 as being unpatentable over Spinoza (US 2012/0022455) in view of Adie et al. (US 2011/0282309). Regarding claim 48, Spinoza discloses the method of claim 42, as set forth above, except for comprising attaching an absorbent pad to the proximal side of the structural sheet. However, Adie teaches a method (fig. 1B) comprising attaching an absorbent pad (110) to the proximal side of the structural sheet (140). It would have been obvious to one having ordinary skill in the art before the effective filling date of the claimed invention to modify Spinoza by adding an absorbent pad, as taught by Adie, for the purpose of removing the fluid from the wound site (par. 0144 of Adie). Regarding claim 49, see the rejection of claim 48. Regarding claim 50, Spinoza in view of Adie discloses the method of claim 49, Adie further teaches wherein: the attaching the absorbent pad (110) to the proximal side of the structural sheet (140, fig. 1B) Spinoza further discloses applying adhesive over the proximal side of the structural sheet (par. 0033); Adie further teaches locating the absorbent pad (110) to cover at least a portion of the adhesive over the proximal side of the structural sheet (see fig. 1B); and attaching the absorbent pad (110) to the proximal side of the structural sheet (140) with the adhesive (see fig. 1B); Spnioza further discloses covering the structural sheet with a peelable backing (par. 0033); and adhering the peelable backing to the attachment pad (218/220). It would have been obvious to one having ordinary skill in the art before the effective filling date of the claimed invention to modify Spinoza by adding an absorbent pad, as taught by Adie, for the purpose of removing the fluid from the wound site (par. 0144 of Adie). Claim(s) 51 is/are rejected under 35 U.S.C. 103 as being unpatentable over Spinoza (US 2012/0022455) in view of Spinoza (US 2010/0305510). Regarding claim 51, Spinoza ‘455 discloses the method of claim 41, as set forth above, except for comprising, after the coupling, applying longitudinally-applied compression to at least a portion of the securement sleeve to shorten the securement sleeve into a compressed configuration and retaining the securement sleeve in the compressed configuration with a compression retainer. However, Spinoza ‘510 teaches a securement sleeve (56, figs. 15a-15b) wherein applying longitudinally-applied compression to at least a portion of the securement sleeve (56) to shorten the securement sleeve into a compressed configuration (see figs. 15a-15b) and retaining the securement sleeve in the compressed configuration with a compression retainer (58/59/60/61/62, figs. 15a-15b and pars. 0091-0094). It would have been obvious to one having ordinary skill in the art before the effective filling date of the claimed invention to modify Spinoza ‘455 by adding a compression retainer, as taught by Spinoza ‘510, for the purpose of supporting the securement sleeve for extension and contraction (par. 0091 of Spinoza ‘510). Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. See PTO 892 form. Any inquiry concerning this communication or earlier communications from the examiner should be directed to DUNG T ULSH whose telephone number is (571)272-9894. The examiner can normally be reached Monday-Thursday 7am-5pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Bhisma Mehta can be reached at 571-272-3383. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /DUNG T ULSH/Primary Examiner, Art Unit 3783
Read full office action

Prosecution Timeline

Dec 18, 2024
Application Filed
Oct 29, 2026
Non-Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12779128
ARRANGEMENT FOR A DRUG DELIVERY DEVICE AND DRUG DELIVERY DEVICE
4y 5m to grant Granted Nov 03, 2026
Patent 12779129
A Wireless data communication circuitry for a drug delivery device
4y 5m to grant Granted Nov 03, 2026
Patent 12773501
Electronic System for a Drug Delivery Device
4y 1m to grant Granted Oct 27, 2026
Patent 12773413
PHARMACEUTICAL HYDROCORTISONE SOLUTION FOR INJECTION DEVICE
2y 6m to grant Granted Oct 27, 2026
Patent 12766262
A Medicament Delivery Device
2y 6m to grant Granted Oct 20, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
79%
Grant Probability
96%
With Interview (+17.3%)
2y 11m (~1y 1m remaining)
Median Time to Grant
Low
PTA Risk
Based on 390 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month